CRC Research Update — November 04, 2026
Today's colorectal cancer research highlights
Curated CRC research, accessible, accurate, actionable
The CRC Digest
Wednesday, November 04, 2026
IMPORTANT: The CRC Digest curates and summarizes publicly available research for informational and educational purposes only. Nothing in this newsletter constitutes medical advice, diagnosis, or treatment recommendation. The information provided should not be used as a substitute for professional medical advice. Always seek the guidance of your physician or other qualified health provider with any questions regarding a medical condition or treatment. Content is generated with AI assistance and reviewed by the editorial team. We are not medical professionals. Individual results, treatments, and outcomes vary.
CRC Research Update
-
RESEARCH
Patient-derived organ-on-a-chip platform predicts chemotherapy response in locally advanced CRCFrom a cohort of 14 primary locally advanced CRC cases, researchers engineered 8 patient-specific organ-on-a-chip models that successfully stratified patients into distinct response groups for FOLFOX versus FOLFIRI. (Bioeng Transl Med)
-
RESEARCH
Oxaliplatin resistance linked to therapy-induced senescence and palmitic acid metabolismPreclinical research identified ADORA1-driven palmitic acid synthesis as a key driver of therapy-induced senescence and oxaliplatin resistance in locally advanced CRC; senolytic treatment restored oxaliplatin sensitivity in lab models. (Oncogene)
-
LIVING WITH CRC
Exercise during adjuvant chemotherapy improves survival and quality of lifeA systematic review of nine studies encompassing 4,070 stage II-III CRC patients, of whom 631 participated in structured exercise interventions, found that engagement in physical activity was associated with improvements in overall and disease-free survival in selected studies, though outcomes were highly heterogeneous; quality of life findings generally favored exercise, with some studies reporting reduced treatment-related toxicities including fatigue and neurotoxicity. (Cancer Epidemiol)
-
SCREENING
FIT-based screening in Chile would require 440,000 colonoscopies for target populationA national health survey of 892 individuals aged 50-75 found a 17.46% FIT positivity rate, translating to an estimated colonoscopy demand of 440,443 individuals and requiring substantial capacity expansion across Chilean regions. (Rev Gastroenterol Peru)
Today's research spans precision tools for treatment selection, metabolic drivers of resistance, and the role of exercise and diet in CRC outcomes.
Get CRC research intelligence delivered weekly, free.
SubscribeCRC Digest
Not Medical Advice
The CRC Digest provides research summaries for informational and educational purposes only. This is not medical advice. Always consult your healthcare provider before making any decisions about your care.
Content is curated with AI assistance and reviewed by the editorial team.
Browse Past Issues · Read our full disclaimer · Manage subscription
Useful? Forward it to a colleague. Many of the topics named here have a live research dossier, trajectory and evidence, at Signal Bureau.
Got this from a colleague? Subscribe here. We only ever add readers who sign themselves up.
Evolution Accelerator, Inc. (dba Evolution Labs) · 3941 Park Dr., Suite 20341, El Dorado Hills, CA 95762
You are receiving this because you subscribed to CRC Digest (self-serve signup)
Unsubscribe: honored promptly, no login required. · Privacy policy · Manage or delete your data